Michael Gilmore Wins Shark Tank Award to Advance Precision Therapy Against Drug-Resistant Bacteria
Michael Gilmore, PhD, is one of six winners of Mass General Brigham's inaugural Integrated Shark Tank competition.
News
Sort & Filters
Filters
8 results 1 filter applied
8 results 1 filter applied
Camille André, PhD, PharmD, Wins Boston Innovate2Impact Competition
Camille André, PhD, won the Boston Innovate2Impact Pitch Competition for her clinical infectious disease research.
Study Led by Michael Gilmore, PhD, Identifies Pathway for how Enterococcus Faecalis Bacteria Causes Antibiotic-Resistant Infection
A new study led by a research team from Harvard Medical School and Mass. Eye and Ear, describes how bacteria adapted to the modern hospital environment and repeatedly cause antibiotic-resistant bloodstream infections. This study examined one of the first...
Researchers develop new class of antibiotics to fight leading superbugs
In a significant advance against drug-resistant superbugs, investigators supported by the Harvard-wide Program on Antibiotic Resistance have identified a new class of synthetic antibiotics that have been shown to be effective against Staphylococcus aureus...
Antibiotic-resistant microbes date back to 450 MYA, well before the age of dinosaurs
Survival of mass extinctions helps to explain near indestructible properties of hospital "superbugs" Boston, Mass. — Leading hospital “superbugs,” known as the enterococci, arose from an ancestor that dates back 450 million years — about the time when...
Michael Gilmore, PhD, chairs $20 million antibiotic-resistance challenge
In March 2017, Michael Gilmore, PhD, Director of the Harvard Infectious Disease Institute, chaired a blue ribbon panel that reviewed the most promising applications for the Antimicrobial Resistance Diagnostic Challenge--a $20 million federal prize...
Mass. Eye and Ear team discovers, successfully treats new variant of antibiotic-resistant bacterium
Boston, Mass. — Researchers at Massachusetts Eye and Ear have discovered a new mutation in a highly antibiotic-resistant strain of E. coli that resists clearance by the body’s own immune system by inhibiting white blood cells that ordinarily kill and...
Scientists Discover New Properties of Microbes That Cause Common Eye Infection
Findings described in Nature Communications BOSTON, MASS. – Scientists from Massachusetts Eye and Ear/Harvard Medical School Department of Ophthalmology have used the power of new genomic technology to discover that microbes that commonly infect the eye...